3 drugs could reduce mortality in patients with severe COVID

Differences in ICU patients who recovered or died from COVID-19 have helped researchers identify three drugs that could work against severe disease.

Related Keywords

Montreal ,Quebec ,Canada ,Canadian ,David Langlais ,Erwin Schurr ,Mcgill Genome Centre ,Emergency Fund ,Immunity Initiative ,Canadian Institutes Of Health Research ,Mcgill School Of Biomedical Sciences ,Mcgill University Interdisciplinary Infection ,Immunity In Global Health Program ,Mcgill University Health Centre ,Canadian Centre For Computational Genomics ,Science Advances ,Vinicius Fava ,Research Institute ,Peripheral Blood Mononuclear Cells ,Biomedical Sciences ,Mcgill Genome ,Infectious Diseases ,Global Health Program ,Canadian Centre ,Computational Genomics ,Canadian Institutes ,Health Research ,